PTN News

  • POP02 Includes Children with Down Syndrome September 9, 2021
    The POP02 study continues to enroll participants at an impressive rate. Nearly 15 participants enrolled in POP02 are children with Down Syndrome (DS). Enrolling children with DS in clinical trials helps achieve the goals put forth by INCLUDE. The purpose of the INCLUDE project is to enhance clinical trial support for medication usage in children with ...
  • The ABC Science Collaborative Shares “The Year in Review and a Path Forward” August 17, 2021
    With support from the Pediatric Trials Network (PTN), The ABC Science Collaborative recently produced “The Year in Review and a Path Forward.” This summary of the current science reflects feedback from leading scientists from 13 states across the nation. The science highlights proven best practices to safely return to school in the wake of COVID-19. Schools ...
  • PTN Digoxin Study Reaches Enrollment Goal July 29, 2021
    The Pediatric Trial Network’s (PTN) Digoxin study recently reached the targeted enrollment goal for its study population of infants with Congenital Heart Disease (CHD). Thanks to the hard work and diligence of the clinical care team part of this study, including the PTN team, the target enrollment goal was timely and successfully met to move ...
  • Enrollment Goal Rapidly Approaches for PTN Digoxin Study March 26, 2021
    The Pediatric Trial Network’s (PTN) Digoxin study is rapidly approaching an enrollment milestone for its unique study participant population. Digoxin’s original study timeline projected enrollment to be completed by the end of May 2021. However, due to the onset of the COVID-19 pandemic and related shutdowns and delays, the study team adjusted its target to finish enrollment ...
  • POP02 Enrolls Participants in Record Speed March 12, 2021
    The Pediatric Trials Network (PTN), NICHD Funded, Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children per Standard of Care (POP02) Study has activated new sites in record speed. In less than one year, the team selected approximately 60 sites and worked to activate >35 sites across the US and Canada. Site teams have ...
  • 2019/2020 PTN Annual Review Now Available March 5, 2021
    The 2019/2020 PTN Annual Review is recognition of all the hard-earned accomplishments of the Network. We look forward to all that is to come in 2021. Read the complete review here.
  • First Child with Down syndrome to Enroll in PTN Study December 18, 2020
    The Pediatric Trials Network (PTN) has enrolled the first child participant with Down syndrome into the Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children per Standard of Care (POP02) study. This marks an exciting and significant milestone for the network. As part of the INCLUDE initiative, a directive from the National Institute of ...
  • Anesthesia and Analgesics in Children (ANA) Hydromorphone Cohort Reaches Study Milestone November 9, 2020
    The Pediatric Trials Network (PTN) Anesthesia and Analgesics in Children (ANA) study has recently closed enrollment for its hydromorphone drug of interest (DOI) cohort (or group of study participants), a major study milestone. This means the goal for participant enrollment for this DOI cohort has been reached for this pharmacokinetic (PK) study, and researchers can ...
  • INCLUDE Project Gains Perspective November 1, 2020
    The INCLUDE directive calls for a trans-NIH research initiative to address critical health and quality-of-life needs for individuals with Down syndrome across the lifespan. One of the three primary components of the INCLUDE initiative is to support clinical trials on conditions and diseases that affect people with Down syndrome, both to accelerate the development of new ...
  • PTN Studying Multi-System Inflammatory Syndrome in Children October 21, 2020
    While there have been relatively few confirmed cases and deaths from COVID-19 in children, researchers have been reporting an increased incidence of multi-system inflammatory syndrome in children (MIS-C) that is associated with prior or concurrent SARS-CoV-2 infections in children. Between March and October 1, 2020, over 1,000 MIS-C patients were reported from 44 state health ...
 
 

News icon

news